Literature DB >> 2210245

Alpha 1-antitrypsin excretion in stool in normal subjects and in patients with gastrointestinal disorders.

B Strygler1, M J Nicar, W C Santangelo, J L Porter, J S Fordtran.   

Abstract

Fecal clearance of plasma alpha 1-antitrypsin is used as a measure of protein leakage into the intestinal tract. In this study, the alpha 1-antitrypsin concentration in stool and the plasma clearance of alpha 1-antitrypsin in normal subjects and in a consecutive series of patients with chronic diarrhea, malabsorption, or unexplained hypoalbuminemia was determined. The normal subjects were studied in their usual state and also when they had diarrhea secondary to ingestion of lactulose, sorbitol, sodium sulfate, or phenolphthalein. The study first concluded that induced diarrhea can cause an increase in alpha 1-antitrypsin clearance; if this is not considered in establishing normal values, there may be an overdiagnosis of excess protein leakage in patients with diarrhea. Second, there is a highly significant statistical correlation (P less than 0.001) between alpha 1-antitrypsin clearance and serum albumin concentration. On average, the serum albumin falls below 3.0 g/dL (30 g/L) when the alpha 1-antitrypsin clearance exceeds 180 mL/day, a value that is about threefold higher than the upper limit of normal. Third, three of nine patients with microscopic/collagenous colitis had elevated clearance of alpha 1-antitrypsin; by contrast, abnormal alpha 1-antitrypsin clearance was not found in 23 patients with idiopathic secretory diarrhea. Fourth, fecal alpha 1-antitrypsin concentration is not a reliable index of abnormal alpha 1-antitrypsin clearance.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2210245     DOI: 10.1016/0016-5085(90)91165-3

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  23 in total

1.  Protein losing enteropathy in critically ill adult patients with burns: a preliminary report.

Authors:  Balasubramanian Venkatesh; Jenny Gough; David R Ralston; Michael Muller; Stuart Pegg
Journal:  Intensive Care Med       Date:  2003-11-21       Impact factor: 17.440

2.  Guidelines for the investigation of chronic diarrhoea, 2nd edition.

Authors:  P D Thomas; A Forbes; J Green; P Howdle; R Long; R Playford; M Sheridan; R Stevens; R Valori; J Walters; G M Addison; P Hill; G Brydon
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

3.  Retractile mesenteritis presenting as protein-losing gastroenteropathy.

Authors:  Bahe Rajendran; Donald R Duerksen
Journal:  Can J Gastroenterol       Date:  2006-12       Impact factor: 3.522

4.  Anaemia in Waldmann's disease: A rare presentation of a rare disease.

Authors:  Shahira A El-Etreby; Ahmed Y Altonbary; Mohamed El Sorogy; Wagdi Elkashef; Jehan A Mazroa; Monir H Bahgat
Journal:  World J Gastrointest Endosc       Date:  2015-05-16

5.  Protein-Losing Enteropathy and Gastropathy.

Authors:  Brian R. Landzberg; Mark B. Pochapin
Journal:  Curr Treat Options Gastroenterol       Date:  2001-02

6.  Faecal alpha 1 antitrypsin as a marker of gastrointestinal disease in HIV antibody positive individuals.

Authors:  D Sharpstone; A Rowbottom; M Nelson; B Gazzard
Journal:  Gut       Date:  1996-02       Impact factor: 23.059

Review 7.  Current Role of Blood and Urine Biomarkers in the Clinical Care of Adults with Congenital Heart Disease.

Authors:  Saurabh Rajpal; Laith Alshawabkeh; Alexander R Opotowsky
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

8.  Cell-specific expression of alpha 1-antitrypsin in human intestinal epithelium.

Authors:  E P Molmenti; D H Perlmutter; D C Rubin
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

Review 9.  Clinical practice. Protein-losing enteropathy in children.

Authors:  Marjet J A M Braamskamp; Koert M Dolman; Merit M Tabbers
Journal:  Eur J Pediatr       Date:  2010-06-23       Impact factor: 3.183

Review 10.  Diagnosing small bowel malabsorption: a review.

Authors:  Cinzia Papadia; Antonio Di Sabatino; Gino Roberto Corazza; Alastair Forbes
Journal:  Intern Emerg Med       Date:  2012-11-21       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.